National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

amoxicillin-clavulanate potassium
A combination of the semisynthetic broad-spectrum antibiotic amoxicillin and the beta-lactamase enzyme inhibitor clavulanate potassium. Clavulanate potassium increases the serum half-life of amoxicillin by inhibiting beta-lactamase-mediated metabolism of amoxicillin. Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin binding proteins and inhibiting peptidoglycan synthesis, a critical component of bacterial cell walls. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Augmentin

Previous:ammonium trichlorotellurate, Amnesteem, amonafide dihydrochloride, amonafide L-malate, amoxicillin
Next:Amoxil, amphotericin B deoxycholate, ampicillin sodium/sulbactam sodium, Ampligen, Amplimexon